Superimposed preeclampsia is a pregnancy complication that develops when a woman who already has chronic high blood pressure before or early in pregnancy goes on to develop preeclampsia, typically after 20 weeks of gestation. It affects roughly 20% of pregnancies in women with chronic hypertension and carries higher risks for both mother and baby than either chronic hypertension or preeclampsia on its own.
How It Differs From Regular Preeclampsia
In a typical case of preeclampsia, a previously healthy woman develops high blood pressure and signs of organ stress for the first time after 20 weeks of pregnancy. Superimposed preeclampsia starts from a different baseline: the woman already has elevated blood pressure (140/90 mm Hg or higher) that was documented before pregnancy or before the 20-week mark. The “superimposed” label means preeclampsia is layering on top of a pre-existing condition rather than appearing out of nowhere.
This distinction matters because it changes how the condition is detected. When blood pressure is already high, the usual warning sign of preeclampsia (a new rise in blood pressure) is harder to spot. Instead, doctors look for a sudden worsening of blood pressure beyond the patient’s established pattern, new protein in the urine, or signs that organs like the liver, kidneys, or blood-clotting system are beginning to struggle.
What Triggers It
The underlying problem involves the blood vessels that supply the placenta. In a healthy pregnancy, these vessels widen and become more flexible to deliver a large volume of blood to the growing baby. In women with chronic hypertension, the blood vessels are already stiffer and under more stress. When the placenta doesn’t get adequate blood flow, it releases signals into the mother’s bloodstream that damage the lining of blood vessels throughout her body. This widespread vascular injury is what drives the organ problems that define preeclampsia.
Because the cardiovascular system is already compromised before pregnancy, the threshold for this cascade to begin is lower. That’s why one in five women with chronic hypertension will develop superimposed preeclampsia, compared to the roughly 2% to 8% preeclampsia rate in the general pregnant population.
Signs and Symptoms to Watch For
The hallmark signs include a sharp jump in blood pressure that’s harder to control than before, new protein spilling into the urine, or a significant increase in protein levels if some was already present. A urine protein level above 300 mg in a 24-hour collection, or a protein-to-creatinine ratio above 0.3 on a single sample, meets the diagnostic threshold.
Beyond blood pressure and urine changes, superimposed preeclampsia can show up as:
- Liver involvement: pain in the upper right abdomen or below the breastbone, along with elevated liver enzymes
- Low platelet count: a drop below 100,000 per microliter, which impairs the blood’s ability to clot
- Visual or neurological changes: blurred vision, seeing spots, or severe headaches that don’t respond to typical remedies
- Fluid in the lungs: shortness of breath that comes on suddenly
- Fetal growth restriction: the baby measuring smaller than expected because reduced blood flow through the placenta limits nutrient delivery
When any of these features appear alongside worsening hypertension, the condition is classified as superimposed preeclampsia with severe features, which changes the urgency of the treatment plan.
Risks for Mother and Baby
Superimposed preeclampsia carries greater maternal and fetal risks than preeclampsia developing in a previously healthy woman. In one study of women with chronic hypertension who developed superimposed preeclampsia, 57% delivered before 37 weeks and nearly 39% delivered before 34 weeks. Placental abruption, where the placenta separates from the uterine wall prematurely, occurred in about 6% of affected pregnancies. Fetal growth restriction and stillbirth are also elevated concerns.
For the mother, the risks extend to any organ system the condition reaches: kidney injury, liver damage, seizures (eclampsia), and stroke in the most severe cases. The earlier in pregnancy the condition appears, the more time it has to cause cumulative damage, and the more likely an early delivery becomes necessary.
How It’s Managed
Delivery is the only definitive cure. The core challenge of management is balancing the mother’s safety against giving the baby more time to mature.
For superimposed preeclampsia without severe features, current guidelines support continuing the pregnancy with close monitoring until 37 weeks, at which point delivery is recommended. Blood pressure is managed with medication to keep it in a safe range, and frequent lab work and fetal monitoring track whether the condition is stable or progressing.
When severe features are present, the approach shifts. If the pregnancy has reached 34 weeks, delivery is typically planned promptly. Before 34 weeks, doctors may try to extend the pregnancy by days or a few weeks under very close surveillance to allow corticosteroid injections to speed up the baby’s lung development. If the mother’s condition deteriorates or the baby shows signs of distress at any point, delivery happens regardless of gestational age.
Reducing Your Risk
Women with chronic hypertension are considered high-risk for preeclampsia, and ACOG recommends low-dose aspirin (81 mg daily) as a preventive measure. It should ideally be started before 16 weeks of gestation and continued daily until delivery. Starting aspirin in this window has been shown to reduce the risk of preeclampsia, though it doesn’t eliminate it entirely.
Good blood pressure control before and during early pregnancy also matters. Women planning a pregnancy who have chronic hypertension benefit from working with their care team to optimize their medications beforehand, since some blood pressure drugs are not safe during pregnancy and need to be switched. Maintaining a healthy weight, staying physically active, and managing any coexisting conditions like diabetes or kidney disease all contribute to lowering the overall risk.
Long-Term Health After Superimposed Preeclampsia
The effects of superimposed preeclampsia don’t necessarily end at delivery. Women who experience any form of preeclampsia face a two- to four-fold higher risk of cardiovascular disease later in life compared to those with uncomplicated pregnancies. This includes higher rates of chronic hypertension, heart disease, and stroke. Research published in the journal Hypertension found that longer duration of preeclampsia before delivery correlates with greater long-term cardiovascular risk, with each additional day between diagnosis and delivery associated with a small but measurable increase in risk, particularly in severe cases.
For women who already had chronic hypertension before pregnancy, this compounding effect makes long-term cardiovascular monitoring especially important. Preeclampsia is increasingly recognized not just as a pregnancy complication but as an early stress test that reveals underlying vascular vulnerability. Women with a history of superimposed preeclampsia benefit from regular blood pressure checks, cholesterol screening, and attention to heart health in the years and decades following delivery.